Pacifica, CA, United States of America

Eric L Stangeland

USPTO Granted Patents = 61 

 

 

Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 566(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
Loading Chart...
61 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Mind of Eric L Stangeland

Introduction:

In the realm of innovation and pharmaceutical advancements, Eric L Stangeland has emerged as a prolific inventor making significant contributions to the field. Hailing from Pacifica, CA (US), Eric is recognized for his groundbreaking work in developing compounds with profound implications for serotonin and norepinephrine reuptake inhibition.

Latest Patents:

Eric's latest patented invention revolves around 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds. These compounds, as defined in the patent specification, serve as potent serotonin and norepinephrine reuptake inhibitors. Alongside their pharmaceutical utility, the invention extends to encompass pharmaceutical compositions containing these compounds, methodologies for their application, and the intricate processes involved in their synthesis.

Career Highlights:

With an impressive portfolio boasting a total of 61 patents, Eric L Stangeland has cemented his status as a pioneering inventor in the pharmaceutical arena. His innovative spirit and dedication to pushing the boundaries of scientific exploration have garnered him widespread acclaim within the industry.

Collaborations:

Eric's professional journey has seen him collaborate with esteemed organizations such as Theravance, Inc. and Theravance Biopharma R&D IP, LLC. Alongside his own inventive prowess, Eric has worked alongside talented individuals like Adam D Hughes and Lori Jean Patterson, collectively contributing to the advancement of pharmaceutical research and development.

Conclusion:

In conclusion, Eric L Stangeland stands as a beacon of innovation, consistently spearheading transformative discoveries in the realm of pharmaceuticals. His remarkable work ethic, coupled with his penchant for inventive solutions, underscores his indelible mark on the field of serotonin and norepinephrine reuptake inhibition. As Eric's legacy continues to unfold, the world eagerly anticipates the next wave of groundbreaking inventions from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…